Autopsy report · NCT02729207

Proof-of-concept Study of NSAID Hydrogel Patch in Treatment of Acute Pain

“Due to lack of patients number”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 5 months before it stopped.
• 6 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Teikoku Seiyaku Co., Ltd.

Sponsor type

Industry

Conditions

Ankle Sprain

Interventions

Esflurbiprofen Hydrogel Patch

Participants

6

Sites

1

Countries

United States

Trials that died the same way

• Endothelial Protection in Convalescent COVID-19 Patients
  “Lack of the eligible patients” (80% match in meaning)
• Serial Evaluation of Drug-Eluting Stents Using OCT (STRUT-OCT)
  “Lack of eligible patients” (79% match in meaning)
• Ridge Preservation Comparing Simultaneous vs. Delayed Grafting
  “Not enough patients available” (79% match in meaning)
• REEDUCATION OF OLFACTORY DISORDERS AFTER A CEREBRAL VASCULAR ACCIDENT IN ADULTS
  “lack of patients” (78% match in meaning)
• Intra-erythrocyte Dexamethasone Versus Placebo in Patients With Steroid-dependent Crohn's Disease
  “due to the difficulty to enroll suitable patients” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.